サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768709

インターベンショナルオンコロジーデバイスの世界市場

Interventional Oncology Devices

出版日
ページ情報
英文 282 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
インターベンショナルオンコロジーデバイスの世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 282 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

インターベンショナルオンコロジーデバイスの世界市場は2030年までに39億米ドルに達する

2024年に27億米ドルと推定されるインターベンショナルオンコロジーデバイスの世界市場は、2024～2030年の分析期間においてCAGR 6.4%で成長し、2030年には39億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである塞栓装置は、CAGR 7.3%を記録し、分析期間終了時には24億米ドルに達すると予測されます。アブレーションデバイス分野の成長率は、分析期間のCAGRで5.3％と推定されます。

米国市場は推定7億410万米ドル、中国はCAGR9.6％で成長予測

米国のインターベンショナルオンコロジーデバイス市場は、2024年に7億410万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 9.6%を牽引し、2030年には予測市場規模9億1,560万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4%と5.7%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界のインターベンショナルオンコロジーデバイス市場- 主要動向と促進要因のまとめ

インターベンショナルオンコロジーデバイスはどのようにがん治療を進めているのか？

インターベンショナルオンコロジーデバイスは、従来の手術の必要性を減らし、周辺組織へのダメージを最小限に抑えながら、腫瘍を正確にターゲットとする低侵襲手術を提供することで、がん治療に革命をもたらしています。これらの機器は、ラジオ波焼灼療法（RFA）、マイクロ波焼灼療法（MWA）、経動脈的化学塞栓療法（TACE）などの画像誘導手技に使用され、腫瘍に直接標的療法を行います。インターベンショナル腫瘍学治療は、肝がん、肺がん、腎がん、骨がんにますます採用されるようになっており、開腹手術に代わるより安全で侵襲の少ない治療法を患者に提供しています。これらの技術は、生存率を向上させ、回復時間を短縮し、従来の手術の適応とならない患者に新たな希望をもたらしています。

どのような技術革新がインターベンショナル・オンコロジーを牽引しているのか？

画像モダリティ、ロボット工学、アブレーション技術における技術的進歩がインターベンショナル腫瘍学の成長を牽引しています。MRI、CT、超音波などの画像技術の革新は、治療中の腫瘍をリアルタイムで高解像度に可視化することを可能にし、治療の精度と安全性を向上させています。ロボットシステムはインターベンションの精度を高め、手の届きにくい部位の腫瘍をより的確に捉えることを可能にしています。マイクロ波焼灼術や冷凍焼灼術を含む新しい焼灼技術は、健常組織へのダメージを最小限に抑えながら腫瘍を破壊する、より効果的な選択肢を提供しています。これらの進歩は、インターベンショナル腫瘍学の能力を拡大し、より広範ながんの治療を可能にしています。

市場セグメンテーションはインターベンショナルオンコロジーデバイスの成長をどのように定義するか？

デバイスの種類には、アブレーションデバイス、塞栓デバイス、サポートデバイスがあり、アブレーションデバイスは低侵襲な腫瘍破壊に広く使用されているため、市場をリードしています。処置にはラジオ波焼灼療法、マイクロ波焼灼療法、経動脈的化学塞栓療法が含まれ、マイクロ波焼灼療法はより大きな腫瘍の治療に高い有効性があるため人気を集めています。インターベンショナルオンコロジーデバイスで治療されるがんの種類には、肝臓がん、肺がん、腎臓がん、骨がんなどがあり、肝細胞がんの有病率の高さから肝臓がんが最大のセグメントとなっています。北米や欧州などの地域では、高度なヘルスケア・インフラが整備されていることや低侵襲治療の導入が進んでいることが市場の大きな伸びにつながっています。

インターベンショナルオンコロジーデバイス市場の成長を促進する要因は？

インターベンショナルオンコロジーデバイス市場の成長は、がん罹患率の増加、低侵襲治療への嗜好の高まり、イメージングおよびアブレーション技術の進歩など、いくつかの要因によってもたらされます。がんの罹患率が世界的に上昇する中、より低侵襲で標的を絞った治療オプションに対する需要が高まっています。インターベンショナル腫瘍学は、患者にとって外傷が少なく、回復が早い手技を提供することで解決策を提供します。リアルタイム・イメージングと精密アブレーションにおける技術革新は、これらの治療の有効性と安全性を向上させることで、市場の成長をさらに促進しています。さらに、ヘルスケア・インフラの改善や先進医療技術へのアクセスを背景に、新興市場でインターベンショナル腫瘍学の採用が増加していることも、市場の拡大に寄与しています。

セグメント

デバイス（塞栓デバイス、アブレーションデバイス、サポートデバイス）、がん種（肝がん、乳がん、肺がん、腎臓がん、前立腺がん、その他のがん種）

調査対象企業の例

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS S.A.
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22106

Global Interventional Oncology Devices Market to Reach US$3.9 Billion by 2030

The global market for Interventional Oncology Devices estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Ablation Devices segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.1 Million While China is Forecast to Grow at 9.6% CAGR

The Interventional Oncology Devices market in the U.S. is estimated at US$704.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$915.6 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Interventional Oncology Devices Market - Key Trends and Drivers Summarized

How Are Interventional Oncology Devices Advancing Cancer Treatment?

Interventional oncology devices are revolutionizing cancer treatment by offering minimally invasive procedures that target tumors with precision, reducing the need for traditional surgery and minimizing damage to surrounding tissues. These devices are used in image-guided procedures such as radiofrequency ablation (RFA), microwave ablation (MWA), and transarterial chemoembolization (TACE), which deliver targeted therapies directly to tumors. Interventional oncology treatments are increasingly being adopted for liver, lung, kidney, and bone cancers, providing patients with safer, less invasive alternatives to open surgery. These technologies are improving survival rates, reducing recovery times, and offering new hope to patients who may not be candidates for traditional surgery.

What Technological Innovations Are Driving Interventional Oncology?

Technological advancements in imaging modalities, robotics, and ablation techniques are driving the growth of interventional oncology. Innovations in imaging technologies, such as MRI, CT, and ultrasound, are enabling real-time, high-resolution visualization of tumors during procedures, improving the accuracy and safety of treatments. Robotic systems are enhancing the precision of interventions, allowing for better targeting of tumors in hard-to-reach areas. New ablation techniques, including microwave ablation and cryoablation, are providing more effective options for tumor destruction while minimizing damage to healthy tissues. These advancements are expanding the capabilities of interventional oncology and allowing for the treatment of a broader range of cancers.

How Do Market Segments Define the Growth of Interventional Oncology Devices?

Device types include ablation devices, embolization devices, and support devices, with ablation devices leading the market due to their widespread use in minimally invasive tumor destruction. Procedures include radiofrequency ablation, microwave ablation, and transarterial chemoembolization, with microwave ablation gaining popularity due to its higher efficacy in treating larger tumors. Cancer types treated with interventional oncology devices include liver, lung, kidney, and bone cancers, with liver cancer being the largest segment due to the high prevalence of hepatocellular carcinoma. The market is growing significantly in regions such as North America and Europe, driven by the availability of advanced healthcare infrastructure and the increasing adoption of minimally invasive treatments.

What Factors Are Driving the Growth in the Interventional Oncology Devices Market?

The growth in the interventional oncology devices market is driven by several factors, including the increasing incidence of cancer, the growing preference for minimally invasive treatments, and advancements in imaging and ablation technologies. As cancer rates rise globally, demand for less invasive and more targeted treatment options is increasing. Interventional oncology offers a solution by providing procedures that are less traumatic for patients and offer faster recovery times. Technological innovations in real-time imaging and precision ablation are further driving market growth by improving the effectiveness and safety of these treatments. Additionally, the rising adoption of interventional oncology in emerging markets, driven by improving healthcare infrastructure and access to advanced medical technologies, is contributing to the expansion of the market.

SCOPE OF STUDY:

The report analyzes the Interventional Oncology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Embolization Devices, Ablation Devices, Support Devices); Cancer Type (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Other Cancer Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS S.A.
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Interventional Oncology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Propels Growth in the Interventional Oncology Devices Market
    • Technological Advancements in Image-Guided Cancer Treatment Strengthen Demand for Interventional Devices
    • Growing Use of Minimally Invasive Procedures Fuels Adoption of Interventional Oncology Devices
    • Expansion of Radiofrequency Ablation and Cryoablation Techniques Drives Market Growth
    • Rising Focus on Targeted Cancer Therapies Expands Addressable Market for Interventional Devices
    • Technological Innovations in Microwave Ablation and Embolization Techniques Propel Market Growth
    • Increasing Adoption of Interventional Oncology in Liver, Lung, and Kidney Cancer Treatment Strengthens Market
    • Focus on Reducing Patient Recovery Time and Treatment Side Effects Fuels Demand for Minimally Invasive Solutions
    • Rising Demand for Image-Guided and Navigation-Assisted Cancer Therapies Expands Market Potential
    • Technological Advancements in Catheter-Based Delivery Systems Propel Growth in Interventional Oncology Devices
    • Increasing Focus on Palliative Care and Symptom Management in Cancer Patients Expands Market Opportunities
    • Rising Awareness of Early Cancer Detection and Treatment Options Strengthens Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Lung cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Kidney Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Interventional Oncology Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • INDIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AFRICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030

IV. COMPETITION